Highlighting the anti-carcinogenic potential of an ayurvedic medicinal plant Swertia Chirata

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 6, 2010, Pages 1445-1449

  Saha, Prosenjit ^a   Das, Sukta ^b  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b Cancer Foundation of India   (India)

Author keywords

Anti inflammatory; Anticarcinogenic; Ayurveda medicines; Swertia chirata

Indexed keywords

EID: 79956075006     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (43)

1. Bajpai MB, Asthana RK, Sharma NK, et al (1991). Hypoglycemic effect of swerchirin from the hexane fraction of Swertiachirayata. Planta Med, 57, 102-4.
2. Chakravarty AK, Mukhopadhyay S, Moitra SK, et al (1994). Syringareinol, a hepatoprotective agent and other constituents from Swertia chirata. Ind J Chem Biol, 33, 405-8.
3. Chandrasekar B, Bajpai MB, Mukherjee SK (1990). Hypoglycemic activity of Swertia chirayita (Roxb.ex Flem) Karst. Ind J Exp Biol, 28, 616-8.
4. Chatterjee A, Pakrashi SC (1995). The Treatise on Indian Medicinal Plants Vol.4. Publ. Information Directorate, CSIR, New Delhi, p92
5. Chowdhury NI, Bandopadhyay SK, Banerjee SN, et al (1995). Preliminary studies on he anti-inflammatory effects of Swertia chirata in albino rats. Ind J Pharmacol, 27, 37-9.
6. CSIR (1982). The wealh of India: raw materials. Publ Inf Directorate New Delhi, 10, 78-81.
7. Duke JA (2002). Handbook of Medicinal Herbs. CRC Press,Washington DC, p190.
8. Dutta SC (1965). A handbook of systematic botany. Ind Publ House, Bombay, 156.
9. Edwards DM (1993). The marketing of non-timber forest product from the Himalayas: the trade between east Nepal and India. Rural Development Forestry Network, 1-21.
10. Iqbal Z, Lateef M, Khan MN, et al (2006). Antihelminthic activity of Swertia chirata against gastrointestinal nematodes of sheep. Fitotherapia, 77, 463-5.
11. Joshi PC, Dhwan V (2005). Swertia chirayata - an overview. Curr Sc, 89, 635-40.
12. Karan M, Vasisht K, Handa SS (1999). Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats. Phytother Res, 13, 95-101.
13. Khanom F, Kayahara H, Tadasa K (2000). Superoxide scavenging and polyendopeptidase inhibitory activities of Bangladeshi indigenous medicinal plants. Biosc Biotech Biochem, 64, 837-40.
14. Kirtikar KR, Basu BD (1984). TITLE???. Indian Med Plants, 3, 1664-6.
15. Kumar KPS, Bhowmik D, Chiranjib, et al (2010). Swertia chirata: A traditional herb and its medicinal uses. J Chem Pharm Res, 2, 262-6.
16. Kumar IV, Paul BN, Asthana R, et al (2003). Swertia chirata mediated modulation of interleukin-1 beta, interleukin-10,interferon-gamma and tumor necrosis factor-alpha in arthritic mice. Immunopharmacol Immunotoxicol, 25, 573-83.
17. Mandal S, Chatterjee A (1987). Structure of chiratanin, a novel dimeric xanthone. Tetrahedron Lett, 28, 1309-10.
18. Mandal S, Das PC, Joshi PC, et al (1992). Anti-inflammatory action of Swertia chirata. Fitotherapia, 63, 122-8.
19. Mandal S, Joshi PC, Das PC (1997). Drug value of Swertia chirata and its phytoconstituents. Bull Medico Etnobotany Res, 18, 82-8.
20. Medda S, Mukhopadhyay S, Basu M (1999). Evaluation of in vitro activity and toxicity of antileishmanial agent in both liposomal and niosomal forms. J Antimicrobial Chemother, 44, 791-4.
21. Mitra SK, Gopumadhavan S, Muralidhar TS (1996). Effect of D-400, an ayurvedic herbal formulation on experimentally induced diabetes mellitus. Phytother Res, 10, 433.
22. Miura T, Ichiki H, Hashimoto I, et al (2001). Anti-diabetic activity of a xanthone compound mangiferin. Phytomedicine, 8, 85-7.
23. Mukherjee S, Sur A, Maiti BR (1997). Hepatoprotective effect of Swertia chirata on rat. Ind J Exp Biol, 35, 384-8.
24. Muruganandan S, Gupta S, Kataria M, et al (2002). Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology, 176, 165-73.
25. Nandkarni KM (1976). Indian Materia Medica, Bombay. Popular Prakashan, Bombay, 1, 1184-6.
26. Rafatullah S, Tariq M, Mossa JS, et al (1993). Protective effect of Swertia chirata against indomethacin and other ulcerogenic agent induced gastric ulcers. Drugs Exp Clin Res, 19, 69-73.
27. Pant N, Jain DC, Bhakuni RS (2000). Ind J Chem Biol, 39, 565-86.
28. Ray S, Majumder HK, Chakravarty AK, et al (1996).Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani. J Nat Prod, 59, 27-9.
29. Reen RK, Karan M, Singh K, et al (2001). Screening of various Swertia species extracts in primary monolayer culture ofrat hepatocytes against carbon tetrachloride-paracetamol induced cytotoxicity. J Ethnopharmacol, 75, 239-47.
30. Roberts JC (1961). Naturally occurring xanthones. Chem Rev,61, 591-605.
31. Saha P (2004). Evaluation of cancer chemopreventive potential of Camellia sinensis and Swertia chirata. Ph.D thesis, Jadavpur Univ., Kolkata.
32. Saha P, Das S (2003). Regulation of hazardous exposure by protective exposure- Modulation of phase II detoxification and lipid peroxidation by Camellia sinensis and Swertia chirata. Teratog Carcinog Mutagen, Suppl 1, 313-22.
33. Saha P, Mandal S, Das A, et al (2004). Evaluation of the anticarcinogenic activity of Swertia chirata Buch Ham. An Indian medicinal plant on DMBA induced mouse skin carcinogenesis model. Phytother Res, 18, 373-8.
34. Saha P, Mandal S, Das A, et al (2006). Amarogentin can reduce hyperproliferation by downregulation of COX II and upregulation of apoptosis in mouse skin carcinogenesis model. Cancer Lett, 244, 252-9.
35. Saxena AM, Bajpai MB, Mukherjee SK (1991). Swerchirin induced blood sugar lowering of streptozotocin treated hyperglycemic rats. Ind J Exp Biol, 29, 674-5.
36. Saxena AM, Bajpai MB, Murthy PS, et al (1993). Mechanism of blood sugar lowering by a swerchirin containing hexane fraction (SWI) of Swertia chirayita. Ind J Exp Biol, 31, 178-81.
37. Saxena AM, Murthy PS, Mukherjee SK (1996). Mode of action of three structurally different hypoglycemic agents: a comparative study. Ind J Exp Biol, 34, 351-5.
38. Scartezzini P, Speroni E (2000). Review on some plants of Indian traditional medicine with anti-oxidative activity. J Ethnopharmacol, 71, 23-43.
39. Sekar BC, Mukherjee B, Chakravarti RB, et al (1987). Effect of different fractions of Swertia chirata on blood sugar level of albino rats. J Etnopharmacol, 21, 175-81.
40. Singha UK, Guru PY, Sen AB, et al (1992). Antileishmanial activity of traditional plants against Leishmania donovani in golden hamsters. Int J Pharmacol, 30, 289-95.
41. Valecha N, Devi UC, Joshi H, et al (2000). Comparative efficacy of ayush-64 vs chloroquine in vivax malaria. Curr Sc, 78, 1120-2.
42. Verma H, Patil PR, Kolhapure RM, et al (2008). Antiviral activity of the Indian medicinal plant extract Swerchia chirata against herpes simplex viruses: a stugy in vitro and molecular approach. Ind J Med Microbiol, 26, 322-6.
43. Williamson EM (2002). Major herbs of ayurveda. Compiled by Dabur Res. Foundation & Dabur Ayurveda Ltd. India. Elsevier Sc. Ltd. London.